Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jan. 03, 2026
Dec. 28, 2024
Dec. 30, 2023
Cash flows from operating activities      
Net earnings $ 11,477 $ 42,060 $ 63,788
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 32,562 14,539 12,702
Right-of-use asset reduction 7,140 7,690 7,693
(Gain) loss on sale of property and equipment (2,093) 1 10
Equity-based compensation expense 13,828 14,558 14,595
Deferred income taxes (7,133) (6,744) (2,749)
Inventory write-down 2,679 1,891 2,601
Impairment 6,967 0 0
Changes in operating assets and liabilities, net of acquisitions:      
Inventories (34,685) (2,118) 2,353
Prepaid expenses and other assets 621 (2,871) 110
Accounts payable 5,204 (1,269) (428)
Other liabilities (14,218) (6,745) (30,034)
Net cash provided by (used in) operating activities 22,349 60,992 70,641
Cash flows from investing activities      
Proceeds from the settlement of net investment hedges 0 1,125 3,775
Payments for net investment hedge (1,072) (870) (1,271)
Proceeds from acquisition working capital adjustment 865 0 0
Payments to acquire businesses, net of cash acquired 0 (203,336) 0
Proceeds from sale of property and equipment 3,905 64 15
Purchases of property and equipment (13,823) (10,073) (14,494)
Net cash provided by (used in) investing activities (10,125) (213,090) (11,975)
Cash flows from financing activities      
Repurchase of common stock (27,507) (9,444) (11,599)
Borrowings on line of credit 17,600 23,687 1,542
Payments on line of credit (26,600) (1,467) (750)
Payments related to tax withholding for net-share settled equity awards (2,347) (3,223) (3,092)
Distributions to redeemable noncontrolling interest (1,749) 0 0
Payments for contingent consideration 0 0 (338)
Net cash provided by (used in) financing activities (40,603) 9,553 (14,237)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 5,111 (6,193) (2,503)
Net increase (decrease) in cash, cash equivalents, and restricted cash (23,268) (148,738) 41,926
Cash, cash equivalents, and restricted cash at beginning of period 184,508 333,246 291,320
Cash, cash equivalents, and restricted cash at end of period 161,240 184,508 333,246
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 158,380 181,768 330,420
Restricted cash included in other assets 2,860 2,740 2,826
Total cash, cash equivalents, and restricted cash 161,240 184,508 333,246
Cash paid during the period for:      
Interest 663 76 68
Non-cash investing and financing activities:      
Right-of-use assets obtained in exchange for lease obligations 8,643 12,463 5,699
Net working capital adjustment receivable 0 778 0
Accrued purchases of property and equipment 1 42 117
Accrued excise tax for repurchase of common stock $ 231 $ 39 $ 54